Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin XR in CKD Stage 1 to 3
NCT02895750Phase 2Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Aug 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: 24-hour blood glucose control at 12 weeks. Started Aug 2017; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02895750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895750.